Table 3 Hazard ratios (95% CI) for development of hepatic steatosis with intermediate-to-high probability of advanced fibrosis based on fibrosis-4 score and NAFLD fibrosis score by heart rate variability.
Quintiles of heart rate variability | For development of HS with intermediate-to-high probability of advanced fibrosis based on fibrosis-4 score | For development of HS with intermediate-to-high probability of advanced fibrosis based on NAFLD fibrosis score | ||||
|---|---|---|---|---|---|---|
Incidence density (/103 PY) | Multivariable-adjusted HRa (95% CI) | HR (95% CI)b in a model with time-dependent variables | Incidence density (/103 PY) | Multivariable-adjusted HRa (95% CI) | HR (95% CI)b in a model with time-dependent variables | |
SDNN quintiles | ||||||
Q1 | 2.9 | 1.16 (0.96–1.41) | 1.51 (1.21–1.88) | 4.7 | 1.41 (1.21–1.65) | 1.56 (1.31–1.85) |
Q2 | 2.2 | 1.22 (1.01–1.48) | 1.45 (1.15–1.82) | 3.0 | 1.20 (1.02–1.42) | 1.36 (1.13–1.63) |
Q3 | 1.7 | 1.08 (0.88–1.32) | 1.40 (1.11–1.77) | 2.4 | 1.09 (0.92–1.29) | 1.26 (1.05–1.52) |
Q4 | 1.4 | 1.02 (0.83–1.25) | 1.36 (1.06–1.73) | 2.0 | 1.02 (0.86–1.22) | 1.14 (0.94–1.39) |
Q5 | 1.2 | 1.00 (reference) | 1.00 (reference) | 1.8 | 1.00 (reference) | 1.00 (reference) |
P for trend | 0.03 | 0.001 | < 0.001 | < 0.001 | ||
RMSSD quintiles | ||||||
Q1 | 3.2 | 1.34 (1.10–1.64) | 1.70 (1.35–2.15) | 4.9 | 1.50 (1.27–1.77) | 1.67 (1.39–2.00) |
Q2 | 2.2 | 1.28 (1.04–1.57) | 1.47 (1.16–1.88) | 3.0 | 1.26 (1.06–1.49) | 1.37 (1.14–1.66) |
Q3 | 1.8 | 1.23 (1.00–1.52) | 1.36 (1.06–1.75) | 2.6 | 1.25 (1.05–1.49) | 1.25 (1.03–1.53) |
Q4 | 1.3 | 1.00 (0.80–1.25) | 1.30 (1.00–1.70) | 1.9 | 1.08 (0.90–1.30) | 1.21 (0.98–1.49) |
Q5 | 1.1 | 1.00 (reference) | 1.00 (reference) | 1.5 | 1.00 (reference) | 1.00 (reference) |
P for trend | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||